The outcomes of margin status after sleeve lobectomy for patients of non–small cell lung cancer
Open Access
- 5 May 2022
- journal article
- research article
- Published by Wiley in Thoracic Cancer
- Vol. 13 (11) , 1664-1675
Abstract
Background: Sleeve lobectomy is recognized as an alternative surgical operation to pneumonectomy because it preserves the most pulmonary function and has a considerable prognosis. In this study, we aimed to investigate the implications of residual status for patients after sleeve lobectomy.Methods: In this retrospective cohort study, we summarized 58 242 patients who underwent surgeries from 2015 to 2018 in Shanghai Chest Hospital and found 456 eligible patients meeting the criteria. The status of R2 was excluded. The outcomes were overall survival (OS) and recurrence‐free survival (RFS). We performed a subgroup analysis to further our investigation.Results: After the propensity score match, the baseline characteristic was balanced between two groups. The survival analysis showed no significant difference of overall survival and recurrence‐free survival between R0 and R1 groups (OS: p = 0.053; RFS: p = 0.14). In the multivariate Cox analysis, we found that the margin status was not a dependent risk factor to RFS (p = 0.119) and OS (p = 0.093). In the patients of R1, N stage and age were closely related to OS, but we did not find any significant risk variable in RFS for R1 status. In the subgroup analysis, R1 status may have a worse prognosis on patients with more lymph nodes examination. On further investigation, we demonstrated no differences among the four histological types of margin status.Conclusion: In our study, we confirmed that the margin status after sleeve lobectomies was not the risk factor to prognosis. However, patients with more lymph nodes resection should pay attention to the margin status.Keywords
Funding Information
- Shanghai Chest Hospital
This publication has 15 references indexed in Scilit:
- Sleeve Lobectomy for Non–Small Cell Lung Cancers: Predictive CT Features for Resectability and Outcome AnalysisAmerican Journal of Roentgenology, 2019
- Does Induction Therapy Increase Anastomotic Complications in Bronchial Sleeve Resections?World Journal of Surgery, 2019
- Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 diseaseLung Cancer, 2016
- Sleeve lobectomy after induction chemoradiotherapyEuropean Journal of Cardio-Thoracic Surgery, 2012
- The Incidence of Perioperative Anastomotic Complications After Sleeve Lobectomy Is Not Increased After Neoadjuvant ChemoradiotherapyThe Annals of Thoracic Surgery, 2009
- Residual disease at the bronchial stump after curative resection for lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2007
- Surgical Techniques and Results for Partial or Circumferential Sleeve Resection of the Pulmonary Artery for Patients with Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2007
- Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLCEuropean Journal of Cardio-Thoracic Surgery, 2005
- Prognostic implications of a positive bronchial resection marginEuropean Journal of Cardio-Thoracic Surgery, 2000
- Safety and efficacy of bronchovascular reconstruction after induction chemotherapy for lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1997